Purpose
To verify effectiveness and safety of a reduced dose schedule of HPV vaccine in preventing cervical cancer to facilitate the rapid introduction of HPV vaccine programs in poor countries with high cervical cancer rates
Grantee
Division
Global Health
Date
MAY 2021
Region served
GLOBAL
Committed amount
$7,646,750
Grant topic
Vaccine Development
Duration (months)
93
Grantee location
Lyon, France
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.